Results 201 to 210 of about 9,354,751 (270)

BAFF and APRIL signaling in the B-cell lineage: implications for the pathogenesis of ANCA-associated vasculitis. [PDF]

Front Immunol
Shimojima Y, Yoshida S, Matsumoto H, Sumichika Y, Asano T, Sato S.   +5 more
europepmc   +1 more source

Complement and immunoglobulin profiles in ANCA-associated vasculitis with renal involvement: a serotype-stratified analysis of disease activity and renal outcomes. [PDF]

Front Immunol
Golubović S, Veselinov V, Đurović V, Popović M, Knežević V.   +4 more
europepmc   +1 more source

Interstitial lung disease in ANCA-associated vasculitis: comment on the article by Chalkia et al. [PDF]

Arthritis Rheumatol
Iannone C, Pellico MR, Harari S, Caporali R.   +3 more
europepmc   +1 more source

Understanding the burden of ANCA-associated vasculitis. [PDF]

Rheumatology (Oxford)
Hellmich B.
europepmc   +1 more source

ANCA-associated vasculitis: a phase-oriented therapeutic framework from immunopathology to precision treatment. [PDF]

Front Med (Lausanne)
Treppo E, Longhino S, Fazzi B, Di Centa L, Fabro C, Quartuccio L.   +5 more
europepmc   +1 more source

The risk of primary lung cancer in ANCA-associated vasculitis: systematic review and meta-analysis. [PDF]

Proc (Bayl Univ Med Cent)
Chaisrimaneepan N, Yingchoncharoen P, Sodsri T, Jakramonpreeya N, Nugent KM.   +4 more
europepmc   +1 more source

Real-world efficacy and safety of avacopan in ANCA-associated vasculitis: a retrospective comparative study. [PDF]

RMD Open
Thiele F, Schneider J, Prager E, Jandova I, Frye BC, Voll RE, Schramm MA, Venhoff N.   +7 more
europepmc   +1 more source

Phenotypic characterization of patients with ANCA-associated vasculitis and diffuse alveolar hemorrhage: a data-driven analysis of a multicentre, retrospective, nationwide cohort. [PDF]

Ann Intensive Care
Gendreau S, Sanna AC, Desnos C, Lombardi R, Malherbe J, Titeca-Beauport D, Reizine F, Porcher R, Terrier B, de Prost N, PLEXHIA investigators.   +10 more
europepmc   +1 more source